This year the European Society for Clinical Microbiology and Infectious Diseases, ESCMID Global, takes place in Vienna, Austria, on 11-15 April. Aurevia’s international team welcomes you to visit our exhibition booth E85 in the exhibition hall, where we proudly present Labquality EQAS by Aurevia - External quality assessment service for microbiology and clinical research, and regulatory affairs and quality assurance services for pharmaceutical and medical and in vitro diagnostic (IVD) devices.
Regulatory affairs and CRO services
The Aurevia team providing CRO services, medical and IVD device product development, testing and clinical and performance studies, post-market surveillance and performance follow-up looks forward to meeting you!
We have long experience in working with IVD device manufacturers and in-house manufacturers in clinical laboratories. We help our customers with fulfilling regulatory requirements on Quality management systems (QMS) as well as with technical documentation and product registration.
To add, we offer clinical research services for both pharmaceutical and medical devices. We have a lot of experience in working with infectious disease clinical trials, and we also know the European regulatory environment well, being able to support you to navigate it.
Our Meeri Säily, Tadeusz Baron and Nina Vartiainen are happy to discuss your possible needs and want to be at your disposal to enable quick, effective and reliable market entry. In case you wish to schedule a meeting, please reach out to Meeri Säily (meeri.saily@aurevia.com)
External Quality Assessment for Microbiology
The microbiological EQA programs are suitable for clinical laboratories and POCT sites performing testing in the areas of bacterial serology, bacteriology, mycology, parasitology, virology and preanalytics for microbiology. While the selection includes schemes for antigen detection, antibody detection, culture, microscopy, MALDI-TOF, multiplex methods and PCR tests, solutions for versatile needs are available. Authentic single donor samples are included in multiple schemes. Over 8000 laboratories worldwide have chosen Aurevia as their primary EQA provider.
Sales director Juha Wahlstedt and customer service manager Minna Kankainen will be available for discussions during the exhibition hours. If you want to book an appointment, please contact juha.wahlstedt@aurevia.com.
Download the Microbiology Product Catalogue here
Distributors Wanted for EQA Service
We are continuously looking for new distributors for our EQA service. Aurevia’s distributor network currently covers Europe, the Middle East, Southeast Asia, South America, and the US. If you already have some experience in distributing external quality assessment services (proficiency testing programs), and you are looking for an international EQA provider, you are very welcome to book an appointment with us. Please contact sales director Juha Wahlstedt, juha.wahlstedt@aurevia.com.
Scientific program
ESCMID 2025 introduces a new exiting program path with a R&D focus (Pipeline Monday), which aims to focus on technological innovations on antimicrobials, vaccines and diagnostics. At Aurevia, we want to support this development of diagnostics throughout their lifecycle from early development to post-market activities.
Please visit also our poster P0330 on ’Neither noro r norovirus GI/GII? Good consensus in international EQA pilot study for norovirus antigen detection’ on Saturday April 12th at 12 -13.30 CET.
Contact us
EQA services
- Juha Wahlstedt: juha.wahlstedt@aurevia.com.
- Minna Kankainen: minna.kankainen@aurevia.com
CRO & regulatory affairs
- Meeri Säily: meeri.saily@aurevia.com
Share this article
